A detailed history of Bank Of Montreal transactions in Exact Sciences Corp stock. As of the latest transaction made, Bank Of Montreal holds 116,496 shares of EXAS stock, worth $6.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
116,496
Previous 222,060 47.54%
Holding current value
$6.37 Million
Previous $15.3 Million 67.91%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $4.36 Million - $7.84 Million
-105,564 Reduced 47.54%
116,496 $4.92 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $1.51 Million - $1.98 Million
26,785 Added 13.72%
222,060 $15.3 Million
Q4 2023

Feb 08, 2024

SELL
$59.06 - $75.72 $29.5 Million - $37.8 Million
-499,808 Reduced 71.91%
195,275 $14.4 Million
Q3 2023

Nov 01, 2023

BUY
$65.94 - $99.04 $8.38 Million - $12.6 Million
127,070 Added 22.37%
695,083 $47.4 Million
Q2 2023

Aug 02, 2023

BUY
$62.68 - $95.05 $35 Million - $53.1 Million
558,317 Added 5758.22%
568,013 $53.3 Million
Q1 2023

Jun 13, 2024

SELL
$47.19 - $70.77 $2.19 Million - $3.29 Million
-46,466 Reduced 20.92%
175,594 $11.9 Million
Q4 2022

Feb 01, 2023

BUY
$30.35 - $53.15 $294,273 - $515,342
9,696 New
9,696 $480,000
Q2 2022

Aug 11, 2022

SELL
$35.61 - $76.23 $75,528 - $161,683
-2,121 Reduced 2.4%
86,432 $3.79 Million
Q1 2022

May 12, 2022

BUY
$57.56 - $82.54 $1.21 Million - $1.73 Million
21,012 Added 31.11%
88,553 $6.33 Million
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $279,052 - $387,517
-3,849 Reduced 5.39%
67,541 $5.26 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $2.16 Million - $2.96 Million
23,882 Added 50.27%
71,390 $6.65 Million
Q2 2021

Aug 12, 2021

BUY
$93.66 - $139.27 $4.45 Million - $6.62 Million
47,508 New
47,508 $6.23 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.68B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.